ViroPharma
ViroPharma Incorporated was a pharmaceutical company that developed and sold drugs that addressed serious diseases treated by physician specialists and in hospital settings. The company focused on product development activities on viruses and human disease, including those caused by cytomegalovirus (CMV) and hepatitis C virus (HCV) infections. It was purchased by Shire in 2013, with Shire paying around $4.2 billion for the company in a deal that was finalized in January 2014. ViroPharma was a member of the NASDAQ Biotechnology Index and the S&P 600.
Wikipage redirect
primaryTopic
ViroPharma
ViroPharma Incorporated was a pharmaceutical company that developed and sold drugs that addressed serious diseases treated by physician specialists and in hospital settings. The company focused on product development activities on viruses and human disease, including those caused by cytomegalovirus (CMV) and hepatitis C virus (HCV) infections. It was purchased by Shire in 2013, with Shire paying around $4.2 billion for the company in a deal that was finalized in January 2014. ViroPharma was a member of the NASDAQ Biotechnology Index and the S&P 600.
has abstract
ViroPharma Incorporated was a ...... ceuticals in a merger in 2008.
@en
foundation place
founding year
key person
location
net income ($)
1.13705E8
number of employees
operating income ($)
product
revenue ($)
1.32417E8
type
Link from a Wikipage to an external page
Wikipage page ID
Wikipage revision ID
743,893,690
subject
hypernym
comment
ViroPharma Incorporated was a ...... hnology Index and the S&P 600.
@en
label
ViroPharma
@en
wasDerivedFrom
homepage
isPrimaryTopicOf
name
ViroPharma Incorporated
@en